Author: MNI Alive | Date: 11 February 2019
Congratulations are in order to Dr. Bankole Johnson, DSc, MD, Chairman, Adial Pharmaceuticals, a clinical-stage biopharmaceutical company focused on the development of treatments for addiction, for being named as the 2019 recipient of the American Society of Addiction Medicine’s (ASAM)( https://www.asam.org) R. Brinkley Smithers Distinguished Scientist Award: http://www.medschool.
The award recognizes and honors an individual who has made highly meritorious contributions in advancing the scientific understanding of alcoholism, its prevention and treatment. The award and lecture will be presented at ASAM’s 50th Annual Conference in April 2019.
The R. Brinkley Smithers and Distinguished Scientist Award and Lecture was established by ASAM in 1995 as a lasting tribute to R. Brinkley Smithers, who influenced American alcoholism policy, theory and treatment. The award recognizes and honors an individual who has made highly meritorious contributions in advancing the scientific understanding of alcoholism and its prevention and treatment.
“This is a great honor for Dr. Johnson and with his leadership we are seeing progress in efforts to find clinically-based solutions to addiction that will help millions struggling with the disease,” said William Stilley, CEO of Adial Pharmaceuticals. “As recently reported in The Lancet, one of the world’s leading medical journals, alcohol is the number one cause of death globally among both men and women ages 15 to 49 years. Dr. Johnson’s work and leadership in the field is aimed to specifically attack this scourge and this recognition highlights a career of dedication to finding answers for those suffering from AUD.”
The ASAM, founded in 1954, is a professional medical society representing more than 6,000 physicians, clinicians and associated professionals in the field of addiction medicine.